Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Babylon (BABY) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

Babylon vs Enzyme — how do they compare? Babylon trades at Rp176.21 (market cap Rp751,8M, Rp100,98M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Babylon is far larger — about 5.6× Enzyme's market cap, and Babylon's circulating supply is 4,3B BABY versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Babylon for 16 Days and Enzyme for 29 Days on average.

BABYMLN
Market Cap
Rp751,8MRp134,13M
Volume (24h)
Rp100,98MRp104,56M
Circulating Supply
4,3B BABY3,3M MLN
Typical Hold Time
16 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Babylon

Babylon (BABY) is currently trading at Rp179.04 with a market cap of Rp770.02M, showing bearish technical signals across most indicators. The asset faces strong selling pressure with moving averages unanimously bearish and oscillators neutral. Key support levels are established at Rp164 (S3) and Rp171 (S2), while resistance begins at Rp183 (PP). Average hold time of 16 days suggests moderate trader patience amid current market conditions.

Overall outlook remains cautious with technical indicators pointing to continued downward pressure. Key opportunities exist near support levels for potential rebounds, while major risks include low liquidity and bearish momentum. Investors should monitor volume patterns and watch for any fundamental developments that could shift market sentiment.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BABY
67% Buy33% Sell
Avg holding period · 16 Days
MLN

No sentiment data available yet.

About Babylon

Babylon is a decentralized protocol that allows Bitcoin staking directly on the Bitcoin blockchain. It uses a shared-security model to extend Bitcoin's security to other decentralized networks. This allows BTC holders to participate in multi-staking while keeping their assets secure on the Bitcoin network.

Read more on BABY

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN